Business Context and Reporting Period
Xylem Inc. filed a Current Report on Form 8-K dated December 14, 2012. The filing reports the entry into a material definitive agreement and the creation of a direct financial obligation.
Key Financial Metrics and Obligations
- Facility Amount: Up to €120,000,000 (Risk Sharing Finance Facility).
- Counterparty: The European Investment Bank (EIB).
- Borrower: Xylem Holdings S.a.r.l. (wholly-owned Luxembourg subsidiary).
- Guarantor: Xylem Inc.
- Drawdown Status: No funds have been drawn as of the filing date.
- Interest Structure: Fixed Rate or Floating Rate (based on EURIBOR, LIBOR, or Sterling rates plus a margin tied to the Company's credit rating).
- Maturity: Loans drawn have a maximum maturity of 12 years.
- Availability: Drawdowns permitted starting no later than 18 months from the agreement date.
Material Changes and Covenants
The agreement introduces specific financial covenants and restrictions not previously disclosed in this context:
- Leverage Ratio: The Company must maintain a maximum leverage ratio of 3.50 (consolidated total indebtedness to consolidated EBITDA) throughout the term.
- Restrictions: Limitations on incurring additional debt, granting liens, and entering into sale and leaseback transactions.
- Standard Provisions: Includes customary representations, warranties, additional covenants, and events of default.
Outlook and Management Commentary
The facility is designed to finance research and development projects from 2013 to 2016. Funds are designated for R&D facilities located in Sweden, Germany, Italy, the United Kingdom, Austria, Norway, and Hungary. The filing does not provide specific revenue, profit, cash flow, or liquidity metrics for the reporting period, as the document focuses solely on the new financing arrangement.
Investor Verification Checklist
- Verify the Company's current consolidated total indebtedness and EBITDA to assess compliance with the 3.50 leverage covenant.
- Confirm the specific credit rating of Xylem Inc. to determine the applicable interest rate margin.
- Monitor the timing of the first potential drawdown (18 months post-agreement) and its impact on future liquidity.
- Review the specific R&D projects in the listed European countries to understand the capital allocation strategy.